ArticlePediatric blood & cancer2026

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.

Bridget Austin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.